Podcast Episodes
Back to SearchMyelofibrosis: Updates from EHA 2023
Episode 286
Drs. Masarova and Mesa discuss myelofibrosis data presented during the 2023 annual meeting of the European Hematology Association.
3 years ago
Semaglutide reduces cardiovascular risk by 20%
Episode 285
Can an obesity drug lower risk for heart disease? Find out about this and more in today's PV Roundup podcast.
3 years ago
Myelofibrosis: Updates from ASCO 2023
Episode 284
Drs. Mesa and Masarova highlight myelofibrosis data presented at the 2023 annual American Society of Clinical Oncology meeting.
3 years ago
Topics from the 2023 Annual Meeting of the Association for Research in Vision and Ophthalmology (Part 2)
Episode 283
Drs. Nudleman and Yiu discuss topics from the 2023 Annual Meeting of the Association for Research in Vision and Ophthalmology Insights in this two-pa…
3 years ago
Universal flu vaccine elicits strong immune response
Episode 282
Can a new vaccine candidate provide broad-spectrum protection against influenza? Find out about this and more in today's PV Roundup podcast.
3 years ago
Topics from the 2023 Annual Meeting of the Association for Research in Vision and Ophthalmology (Part 1)
Episode 281
Drs. Nudleman and Yiu discuss topics from the 2023 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in New Orleans, …
3 years ago
Insights from the 2023 Annual Meeting of the Association for Research in Vision and Ophthalmology
Episode 280
Drs. Emami-Naeini and Sharma discuss data presented at the 2023 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in …
3 years ago
Almost zero risk of HIV transmission with low viral loads
Episode 279
What is the risk of HIV transmission with low viral loads? Find out about this and more in today's PV Roundup podcast.
3 years ago
Specialist Spotlight on Diversity, Equity, and Inclusion in Retinal Medicine
Episode 278
In this specialist spotilight, Drs. Yiu and Emami-Naeini share their insights into Diversity, Equity and Inclusion in retinal medicine including rese…
3 years ago
Specialist Spotlight on Myelofibrosis: JAK inhibitor Drug Choice and Dosing Strategy
Episode 277
In this specialist spotlight, Drs. Kuykendall and Mascarenhas share their insights into JAK inhibitor drug choice in patients with myelofibrosis.
3 years ago